Behçet and LDH/Albumin (NCT06276829) | Clinical Trial Compass
CompletedNot Applicable
Behçet and LDH/Albumin
Turkey (Türkiye)1 participantsStarted 2020-02-01
Plain-language summary
ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls.
Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.
Who can participate
Age range
18 Years – 69 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patients with Behçet's disease aged 18-69
Exclusion Criteria:
* younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial studied something called the LDH/albumin ratio in people with Behçet's disease — can you explain what that ratio measures and whether checking mine could give us useful information about how active my disease is?
2Since this trial has already completed, have the results been published yet, and if so, what did they find about whether the LDH/albumin ratio actually reflects disease severity in Behçet's patients?
3Would it make sense to include LDH and albumin in my regular blood work as a way to track my Behçet's disease over time, based on what this kind of research is showing?
4This was an observational study rather than a treatment trial — does that mean it was looking for a new way to measure disease activity rather than testing a new drug, and how might findings like this eventually change how my condition is monitored?
5Are there other established tools or lab markers already being used to assess Behçet's disease severity that you rely on, and how does the LDH/albumin ratio compare to those in terms of usefulness?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.